ABSTRACT: Pyruvate carboxylase (PC; EC 6.4
INTRODUCTION
The role of bovine pyruvate carboxylase (PC; EC 6.4.1.1) in the regulation of glucose metabolism is critical to the rate of gluconeogenesis from lactate and capacity of the tricarboxylic acid cycle. In dairy cows, expression of the PC gene is significantly increased during transition to lactation and feed restriction (Greenfield et al., 2000; Velez and Donkin, 2005) , although the mechanism of this response is unknown. Increased NEFA and glucocorticoid concentrations (Velez and Donkin, 2005) , as well as changes in plasma fatty acid profiles (Douglas et al., 2007) occur during transition to lactation. These changes coincide with increased PC expression and suggest possible cues for the change in PC mRNA expression.
The bovine PC gene contains 3 promoter regions (3, 2, and 1, 5′ to 3′; Agca et al., 2004) . Alternate expression of the bovine PC promoters results in 6 mRNA variants that differ only in their 5′ untranslated region (Hazelton et al., 2008) . Expression of mRNA products originating from P2 and P3 have been detected in all bovine tissues examined; however, mRNA products of promoter 1 are only detected in glucogenic and lipogenic tissues (Agca et al., 2004) .
Several genes are regulated by fatty acids through changes in promoter activity mediated by transcription factors including PPAR, hepatic nuclear factors (HNF), and sterol regulatory element-binding protein (Jump, 2002; Pawar and Jump, 2003; Watt et al., 2003) . Responsiveness of mouse PC promoters to PPARγ has been established in both white and brown adipose tissue (Jitrapakdee et al., 2005) .
We hypothesized that the effect of feed restriction to increase PC expression is due, at least in part, to changes in fatty acid concentrations and profiles. The objective of this experiment was to examine the direct effect of the fatty acid profile and concentration in serum from control or feed-restricted cows on PC promoter 1 activity.
MATERIALS AND METHODS
Animal use and handling protocols were approved by the Purdue Animal Care and Use Committee.
Animal Handling and Sample Collection
Sixteen mid-lactation, multiparous Holstein cows from the Purdue University Dairy Research and Education Center herd were stratified by previous production and days in milk, and randomly assigned to a control or feed-restricted treatment group (n = 8 per group). Cows were housed in individual tie stalls at the Purdue Dairy Research and Education Center and fed diets formulated to meet or exceed the NRC (2001) guidelines for 600-kg dairy cattle consuming 24.5 ± 0.7 kg/d (Table  1) . Initial BW was 624.3 ± 22 kg, and initial BCS was 2.4 ± 0.1. Cows were 156 ± 25 d in milk and were producing 39.3 ± 5.1 kg of milk/d at the beginning of the experiment. Diets were fed as a total mixed ration once daily between 0630 to 0730 h in amounts that ensured ad libitum consumption and approximately 10 to 15% feed refusals. Cows were milked twice daily at approximately 0700 and 1830 h. Milk yield was recorded daily. Body weights and BCS were obtained at the beginning of the study and on the last day of each period. Body condition was scored by a trained individual using a 5-point scale (Wildman et al., 1982) , and scores were averaged for each cow within day of observation. The experiment consisted of 2 5-d periods. During period 1, all cows were allowed ad libitum access to feed and feed consumption was measured by difference in feed offered and refused. During period 2, cows assigned to the feed-restricted group were given 50% of their individual feed intake determined during period 1, whereas control cows continued to receive ad libitum access to feed. Blood samples (7 mL) were obtained on the last day of each period. Blood samples were collected from the coccygeal vein or artery into evacuated tubes free of anticoagulants (Becton Dickinson, Franklin Lakes, NJ) for separation of serum for fatty acid profiles and cell culture application. Blood was permitted to clot on ice for 20 min and serum was separated by centrifugation at 2,000 × g for 10 min at 4°C. Serum samples were stored at −20°C and used within 7 d in cell culture experiments described below.
Serum fatty acids were extracted as described previously (Folch et al., 1957) . Fatty acid profiles were determined using a Varian 3900 gas-liquid chromatograph equipped with an 8400 autosampler and wallcoated open tubular fused-silica 30 m × 0.32 mm CP wax 52 CP capillary column (Varian Inc., Palo Alto, CA) with helium as the carrier gas as described previously (White et al., 2008) .
Promoter Constructs, Hepatoma Cell Culture, and DNA Transfections
To test the effects of fatty acids on PC promoter activity, cells were transfected separately with promoterluciferase gene constructs containing promoter 1 of the bovine PC gene linked to a reporter for firefly luciferase. The construct for promoter 1 contained bases 613,522 through 612,518 of bovine chromosome 29 (GenBank accession NW_00149451.1), which corresponds to the region from −1,001 through +3 relative to the transcription start site of bovine PC promoter 1 (Hazelton et al., 2008) . A KpnI site and a HindIII site were added to the forward and reverse primers, respectively, to facilitate subsequent ligation into the multiple cloning region of the pGL3-Basic vector (Promega, Madison, Contained 25% dried molasses, 42.75% finely ground corn, 7.5% CaCO 3 , 5% dicalcium phosphate, 6.2% NaHCO 3 , 2% MgO, 2% divalent cation-anion difference plus, 0.5% potassium magnesium sulfate, 2.5% NaCl, 2.025% mineral/vitamin premix (16.11% Ca, 2.11% S, 31,505 mg/kg of Zn, 8,036 mg/kg of Cu, 26,020 mg/kg of Mn, 140 mg/kg of Se, 473 mg/kg of Co, 284 mg/kg of I, 1,440 IU/kg of vitamin A, 416 IU/kg of vitamin D, and 6,647 IU/kg of vitamin E), 0.25% niacinamide (99.5% niacin), 2% yeast culture (Diamond V Mills, Cedar Rapids, IA), 0.213% vitamin E 20,000, 0.062% Rumensin 80, 2% Omingen-AF (Prince-Agri Products, Quincy, IL). WI). Briefly, bovine genomic DNA extracted from liver was used as a template for promoter cloning and sequences amplified by PCR using Taq DNA Polymerase (Qiagen, Valencia, CA). Amplified regions were separated by agarose gel electrophoresis and purified using the QIAquick Gel Extraction Kit (Qiagen). The purified PCR product was ligated into the multiple cloning site of pGL3-basic plasmid (Promega), upstream of the coding region for firefly luciferase. The plasmid DNA from the overnight cultures was isolated with a Wizard Plus SV Miniprep kit (Promega) and quantified by the absorbance of light at 260 nm on a NanoDrop 1000 (NanoDrop Technologies Inc., Wilmington, DE). Sequence and orientation of the promoter region within each construct was verified by sequencing at the Low Throughput Laboratory of Purdue University using the ABI 3700 sequencer (Amersham Biosciences, Piscataway, NJ) and confirmed that products were 100% identical to target promoter sequences. Use of the RVprimer3 binding site, located upstream of the multiple cloning site in the pGL3-Basic vector, during sequencing allowed for confirmation of correct DNA insert directionality. Plasmids containing PC promoter 1 and control vectors described below were generated using a single preparation and used for all experimental replicates for experiments reported here.
For these experiments, the pGL3 plasmids (Promega) were utilized with pGL3-basic as a negative transfection control, a luciferase reporter plasmid containing the SV40 promoter with an enhancer, pGL3-control, and a luciferase reporter plasmid containing the SV40 promoter without an enhancer, pGL3-promoter, were used as positive controls. Cotransfection of cells with a Renilla luciferase plasmid, pRL-CMV (Promega), provided a normalization control for transfection efficiency.
Rat hepatoma (H4IIE) cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA) and cultured in Dulbecco's modified Eagle medium (DMEM) containing 4.5 mM glucose supplemented with 10% fetal bovine serum and 1% antibiotic, antimycotic solution (Sigma, St. Louis, MO). Cells were plated and grown for 24 h in DMEM supplemented with 10% fetal bovine serum and 1% antibiotic, antimycotic solution (Sigma) to achieve 80% confluency.
For cell transfection, a volume of 10 μL of Lipofectamine (Invitrogen, Carlsbad, CA) was gently mixed with 240-μL Opti-MEM reduced serum media (Invitrogen) and incubated at room temperature for 5 min. A total of 4 μg of each plasmid tested and 0.8-μg pRL-CMV was diluted with reduced serum media to a total volume of 250 μL. Diluted plasmids were combined with Lipofectamine (Invitrogen) and incubated at room temperature for 20 min after which a volume of 500 μL was added to 9.6 cm 2 wells containing 2 mL of DMEM supplemented with 1% BSA and cells were incubated for 5 h at 37°C. Cells were incubated in DMEM containing 1% BSA, 10% cow serum, or 10% modified cow serum as described below.
Serum, Treatment Media, and Fatty Acid Combinations
Serum samples collected from cows subjected to feed restriction or full feeding for 5 d, as described above, were pooled within group to create a pool of serum from full-fed control cows (CCS) and a pool of serum from feed-restricted cows (FRCS). Composite samples were filtered through a 0.22-μM syringe filter (Pall Life Sciences, Port Washington, NY). Serum was pooled and utilized within 1 wk of collection and was not heatinactivated before use based on evidence indicating a lack of complement activity in bovine serum in culture (Triglia and Linscott, 1980) and the reduction in cellular activity for heat-treated serum (Giard, 1987) .
To create a modified control cow serum (MCCS), fatty acids were added to CCS to achieve a total fatty acid concentration that matched serum from feed-restricted cows (1.3 mM) but maintained the profile of C14:0, C16:0, C18:0, C18:1n-9 cis, C18:2n-6 cis, and C18:3n-3 cis in CCS. Similarly, CCS was modified by the addition of fatty acids so that the resulting concentration and profile of 14:0, C16:0, C18:0, C18:1n-9 cis, C18:2n-6 cis, and C18:3n-3 cis matched FRCS (MCC-SFR). Fatty acids used supplement CCS to create the modified serums were bound to BSA (Millipore, Billerica, MA) as described previously (Berry et al., 1991) . All treatments were applied in duplicate for 23 h in 3 independent preparations of cells.
Luciferase Activity
After 23 h of incubation, cells were rinsed with 1 × PBS and harvested in a 0.5-mL, 1 × passive lysis buffer (Promega). Cells were removed to a microcentrifuge tube and frozen. Luciferase activity in 20 μL of cell lysates was initiated by the addition of 100 μL of firefly luciferase detection reagent followed by addition of 100 μL of Renilla luciferase detection agent (Progema). Luminescence was quantified using a Tecan GENios Pro spectrofluorometer with Magellan 5.0 software (Tecan, Research Triangle Park, NC). Data were normalized for transfection efficiency by dividing the relative light units detected for firefly luciferase by the corresponding Renilla luciferase relative light units (firefly: Renilla) for each well. Activity of PC promoters for each treatment was normalized to expression of PGL3-basic. All experiments were repeated in 3 separate cell preparations.
Assessment of Cellular Integrity
To assess the effects of cell manipulation on viability, cells were plated on 96-well plates. Media was refreshed after 24 h, and cells were incubated for 23 h at 37°C in media to match incubation conditions for cells used for promoter assessment. The TACS MTT Cell Proliferation Assay (Trevigen, Gaithersburg, MD) was used according to the manufacturer's protocol to determine the effect of treatments on cell viability.
Statistical Analysis
Data were analyzed for normality using the UNIVAR-IATE procedure (SAS Inst. Inc., Cary, NC). Data were analyzed for treatment effect using the MIXED procedure of SAS. The model accounted for the fixed effects of treatment and the random effect of cell preparation. Means were considered different when P < 0.05 and tended to differ when 0.05 ≤ P ≤ 0.1. Tukey-Kramer adjustments were used to separate treatment means when main effects were significant. Data are reported as least squares means and SE.
RESULTS AND DISCUSSION
Feed restriction decreased (P < 0.05) milk production and resulted in a loss of BW and negative energy balance (Table 2 ). Feed restriction also increased (P < 0.05) NEFA concentrations (Table 2) . Changes in serum fatty acid profiles are reported for control and feed-restricted cows (Table 3) . As a percentage of total fatty acids in serum, feed restriction reduced (P < 0.05) myristic acid (C14:0). Relative proportions of stearic acid (C18:0) tended (P = 0.08) to increase and proportions of oleic (C18:1n-9 cis) acid increased (P < 0.05) in serum of feed-restricted cows.
Previous studies on the effects of feed restriction indicated an increase expression of PC mRNA in midlactation cows (Velez and Donkin, 2005) ; however, the factors contributing to the increase in PC were not determined in those studies. Activity of bovine PC promoters contributes to tissue-specific regulation of the gene (Agca et al., 2004) , and mRNA products of promoter 1 are only detected in glucogenic and lipogenic tissues (Hazelton et al., 2008) . In rodents, the proximal promoter (promoter 1) also drives tissue-specific expression in glucogenic and lipogenic tissues and is responsive to PPAR activation (Jitrapakdee et al., 2005) . Changes in circulating factors, such as NEFA, during feed restriction and previous evidence of fatty acid activation of gluconeogenic and lipogenic genes in humans and rodents (Jump, 2002; Pawar and Jump, 2003; Watt et al., 2003) suggest a possible role of circulating fatty acids in the regulation of bovine PC promoter 1. Serum from feed-restricted cows was used with cultured cells expressing bovine PC to determine the direct effects of serum on PC expression. In addition, modified serum pools were formed that mimicked the effects of feed restriction on serum fatty acid profiles on PC expression. The modified serum used in the current study mimicked the profiles of CCS or FRCS by altering the most abundant fatty acid in serum from control and feed-restricted cows (Table 3 ) and, therefore, provides insight in regard to the responsiveness of the PC gene to shifts in concentrations of the most abundant fatty acid in serum.
In H4IIE cells transfected with promoter 1 promoter-luciferase constructs, activity of promoter 1 was increased (P < 0.05) with exposure to FRCS compared with CCS (3.90 vs. 1.75 ± 0.65 arbitrary units, FRCS vs. CCS, respectively; Figure 1 ). There were no effects of any treatments on cell viability as determined by MTT analysis. Activation of PC promoter 1 by serum from feed-restricted cows indicates the presence of unique factors in serum of feed-restricted cows, compared with cows allowed ad libitum access to feed, that are involved in regulation of the PC promoter. Promoter 1 activity in cells treated with BSA did not differ (P ≥ 0.05) from cells treated with CCS or FRCS. Cells incubated with BSA served as a negative control for the absence of serum in the experiment, and the results indicate that BSA alone does not appropriately mimic serum, either due to the presence of fatty acids or other growth and endocrine factors. The data indicate that metabolites, hormones, or other factors contained in CCS act to minimize the expression of PC promoter 1. Previous experiments indicate that cells incubated only with BSA have altered fatty acid efflux (Mashek and Coleman, 2006; Mashek et al., 2007) . The main comparison of interest in these experiments was the activation of PC expression with feed restriction; additional investigations are necessary to determine the factors in serum from control cows that serve to repress PC promoter 1 expression. Within a row, means without a common superscript differ (P < 0.05).
1 FR = feed restricted: during period 1, all cows were allowed ad libitum access to feed. During period 2, control cows were allowed ad libitum access to feed and feed-restricted cows were provided 50% of period 1 ad libitum intake on an individual-cow basis. To examine the role of fatty acids in PC promoter 1, modified serum was created that mimicked the fatty acid profile of feed-restricted cows using CCS as the base. There was no difference (P ≥ 0.05) in promoter 1 activity in cells treated with FRCS, MCCS, or MCC-SFR (3.90 vs. 3.70 and 4.32 ± 0.65 arbitrary units, FRCS vs. MCCS and MCCSFR, respectively). Because the only difference between CCS and the modified CCS is increased concentration of fatty acids, the effect of serum to activate promoter 1 appears to be due to the increased presence of fatty acids. Modified CCS pools activated promoter 1 to the same degree as FRCS, indicating that increased fatty acid concentration, without altering other serum factors, was adequate to activate promoter 1.
Activation of promoter 1 in vitro by exposure to serum from feed-restricted cows, compared with serum from control cows, indicates that factors that regulate promoter 1 during feed restriction are found in circulation. Modifying the fatty acid concentrations of serum from control cows suggests that the majority of the effect on PC promoter 1 is through changes in fatty acid concentrations in serum. These findings corroborate data that demonstrate that bovine PC promoter 1 is differentially responsive to individual fatty acids (White et al., 2009) . Fatty acids were not added individually to serum in the experiments reported here and a dose response was not evaluated; therefore, we are uncertain whether the effects of fatty acids on PC promoter 1 are due to a change in fatty acid concentration, a change in fatty acid profile, or both. Likewise, responsiveness to fatty acids other than C14:0, C16:0, C18:0, C18:1n-9 cis, C18:2n-6 cis, and C18:3n-3 cis have not been evaluated, and it is plausible that PC promoter 1 may respond to fatty acids that are present in serum at lesser concentrations. The lack of difference between promoter activity in cells treated with FRCS and MCCS, or MCCSFR, however, would suggest that Percentage of total fatty acids calculated by supplementing serum from control cows with C14:0, C16:0, C18:0, C18:1n-9 cis, C18:2n-6 cis, and C18:3n-3 cis.
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SE of least squares means.
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Modified control cow serum, created by the addition of fatty acids to achieve a total fatty acid concentration that matched serum from feedrestricted cows but maintained the profile of C14:0, C16:0, C18:0, C18:1n-9 cis, C18:2n-6 cis, and C18:3n-3 cis in control cow serum. Modified control cow serum to match FR, created by the addition of fatty acids to control cow serum so that the resulting concentration and profile of C14:0, C16:0, C18:0, C18:1n-9 cis, C18:2n-6 cis, and C18:3n-3 cis matched feed-restricted cow serum at a total NEFA concentration of 1,300 μM.
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Not detected MCCSFR: modified serum pools were designed to reflect fatty acid profiles from feed. the contribution for fatty acids other than 14:0, C16:0, C18:0, C18:1n-9 cis, C18:2n-6 cis, and C18:3n-3 cis toward PC promoter 1 regulation is likely to be minor.
These data indicate that bovine PC promoter 1 is responsive to fatty acids. Given the regulation of transcription for several other genes by fatty acids acting through PPARα, HNF, and sterol regulatory elementbinding protein in liver, it is likely that bovine PC promoter 1 is subject to similar regulation. Data reported elsewhere indicate that bovine PC promoter 1 is responsive to a PPARα-agonist exposure in vitro (White et al., 2009) . Activation of PPARα is primarily by 18-, 20-, and 22-carbon fatty acids (Jump, 2002; Pawar and Jump, 2003) . Therefore, increased concentrations of stearic (C18:0) and oleic (C18:1n-9 cis) acids in serum from feed-restricted cows may act to induce PC promoter 1 gene promoter activity through PPARα activation. Alternatively, fatty acids such as palmitic acid can stimulate HNF-4 (Jump and Clarke, 1999) , a positive transcriptional regulator of several hepatic genes (Watt et al., 2003) . Although the concentration of palmitic acid was not altered (P ≥ 0.05) by feed restriction, increased (P < 0.05) NEFA in serum from feed-restricted cows results in increased concentrations of palmitic acid (C16:0) in FRCS compared with CCS, which may have contributed to activation of PC promoter 1. Although further investigation is needed to identify the mode of action of fatty to coordinated changes in bovine PC promoter 1 activity, the present data support regulation of PC promoter 1 by fatty acids that are altered in serum in response to feed restriction and negative energy balance. Figure 1 . Effect of serum from full-fed and feed-restricted cows and serum modified to match fatty acid concentrations and profiles during feed restriction on bovine pyruvate carboxylase promoter 1 activity. Cells were incubated for 23 h in the presence of 1% BSA, 10% serum from either control cows (CCS) or feed-restricted cows (FRCS), modified control cow serum (MCCS), or modified control cow serum that matched the concentration and profile of fatty acids in feed-restricted cow serum (MCCSFR). The H4IIE cells were transfected with promoter-luciferase constructs containing pyruvate carboxylase promoter 1 in a pGL3-basic luciferase vector. Data shown are means for promoter expression and the associated SE (0.60).
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